Showing 1 - 10 of 1,373
the pharmaceutical industry in Mexico. The analysis reveals some linkages between management practices and learning at …
Persistent link: https://www.econbiz.de/10009476008
multinomial logit regression techniques using survey data about pharmaceutical firms in Mexico. We find that wages and the …Presented at the GLOBELICS 6th International Conference 2008 22-24 September, Mexico City, Mexico. …
Persistent link: https://www.econbiz.de/10009475857
We draw on diverse data sets to compare the institutional organization of upstream life science research across the United States and Europe. Understanding cross-national differences in the organization of innovative labor in the life sciences requires attention to the structure and evolution of...
Persistent link: https://www.econbiz.de/10015217411
This paper is explorative in nature. Based on an empirical analysis of two different industrial settings (life sciences, LS; information and communication technologies, ICT), it investigates network growth and firm growth in networks. We find a remarkable correspondence between a few fundamental...
Persistent link: https://www.econbiz.de/10015217412
position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in … in pharmaceuticals: 1) The size and the structure of the biomedical education and research systems; 2) Some basic …
Persistent link: https://www.econbiz.de/10015217413
the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the …
Persistent link: https://www.econbiz.de/10015217420
In the present paper, it is attempted to empirically verify the impact of economic liberalization on the R&D behaviour of Indian pharmaceutical firms controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of...
Persistent link: https://www.econbiz.de/10015218033
his paper investigates the relationship between various measures of intangible capital and the market valuation of young biopharmaceutical firms. We employ a non-linear model to measure the impact of R&D, patents, alliances, organizational capital, and mergers on the value of 349...
Persistent link: https://www.econbiz.de/10015261371
Much research has been carried out on the accumulation and effective use of knowledge as a companyspecific form of intellectual property. However, insufficient attention has been given to research focusing on the effects of micro-level knowledge absorption and its effective use. In this paper,...
Persistent link: https://www.econbiz.de/10015238868
This paper reports on the findings of interviews conducted with Hungarian firms on their overall business and innovation strategies and innovation activities to pursue three interconnected aims: a) better understand firm behaviour by analysing qualitative features of innovation processes...
Persistent link: https://www.econbiz.de/10015242406